{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:06:55Z","timestamp":1770066415536,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.ahj.2005.12.015","type":"journal-article","created":{"date-parts":[[2006,8,11]],"date-time":"2006-08-11T07:08:58Z","timestamp":1155280138000},"page":"312-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post\u2013myocardial infarction patients"],"prefix":"10.1016","volume":"152","author":[{"given":"Richard P.","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry R.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna P.","family":"Pilbrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris M.","family":"Frampton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W.","family":"Troughton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim G.","family":"Yandle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"Skelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Mark","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicky A.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2005.12.015_bib1","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1073\/pnas.89.14.6457","article-title":"Molecular basis of AMP deaminase deficiency in skeletal muscle","volume":"89","author":"Morisaki","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ahj.2005.12.015_bib2","doi-asserted-by":"crossref","first-page":"C795","DOI":"10.1152\/ajpcell.1986.251.5.C795","article-title":"Importance of purine nucleotide cycle to energy production in skeletal muscle","volume":"251","author":"Flanagan","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ahj.2005.12.015_bib3","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1172\/JCI116455","article-title":"Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect","volume":"91","author":"Morisaki","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2005.12.015_bib4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0008-6363(03)00497-8","article-title":"Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation\u2014a potential mechanism of protection in heart failure","volume":"59","author":"Kalsi","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2005.12.015_bib5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1172\/JCI111265","article-title":"Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle","volume":"73","author":"Sabina","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2005.12.015_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/A:1025401026441","article-title":"Modulation of cardiac remodeling by adenosine: in vitro and in vivo effects","volume":"251","author":"Villarreal","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ahj.2005.12.015_bib7","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/01.CIR.95.6.1363","article-title":"Plasma adenosine levels increase in patients with chronic heart failure","volume":"95","author":"Funaya","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.12.015_bib8","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/01.CIR.99.11.1422","article-title":"Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure","volume":"99","author":"Loh","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.12.015_bib9","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0735-1097(00)00850-0","article-title":"A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease","volume":"36","author":"Anderson","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.12.015_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cardfail.2003.10.008","article-title":"A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction","volume":"10","author":"Yazaki","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2005.12.015_bib11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.amjcard.2004.02.011","article-title":"Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome)","volume":"93","author":"Gastmann","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.12.015_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijcard.2004.03.014","article-title":"AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization","volume":"101","author":"Andreassi","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2005.12.015_bib13","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure: the Framingham study","volume":"285","author":"McKee","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.12.015_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/hrt.81.2.114","article-title":"Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction","volume":"81","author":"Richards","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2005.12.015_bib15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0735-1097(02)02927-3","article-title":"ACE gene polymorphism interacts with LVEF and BNP levels to predict mortality following myocardial infarction","volume":"41","author":"Palmer","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.12.015_bib16","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1161\/01.CIR.0000070953.76250.B9","article-title":"B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction","volume":"107","author":"Richards","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.12.015_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/ard.53.5.353","article-title":"New method for detection of C34-T mutation in the AMPD1 gene causing myoadenylate deaminase deficiency","volume":"53","author":"Gross","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ahj.2005.12.015_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2005.12.015_bib19","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.ehj.2004.07.007","article-title":"Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure","volume":"25","author":"Gustafsson","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2005.12.015_bib20","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ehj.2004.01.010","article-title":"Impact of diabetes mellitus on long-term survival in patients with congestive heart failure","volume":"25","author":"De Groote","year":"2004","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.ahj.2005.12.015_bib21","first-page":"I15","article-title":"Treatment of heart failure with beta-blockers. Mechanisms and results","volume":"95","author":"Bohm","year":"2000","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.ahj.2005.12.015_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","article-title":"Renal function, neurohormonal activation, and survival in patients with chronic heart failure","volume":"102","author":"Hillege","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.12.015_bib23","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1053\/euhj.1999.1746","article-title":"Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1","volume":"20","author":"Tsutamoto","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2005.12.015_bib24","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ehj.2003.07.005","article-title":"N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure","volume":"24","author":"Gardner","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2005.12.015_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/pcad.2000.0420273","article-title":"Risk stratification after acute myocardial infarction in the reperfusion era","volume":"42","author":"Michaels","year":"2000","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ahj.2005.12.015_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-9149(86)90234-1","article-title":"Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest","volume":"58","author":"Gundersen","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.12.015_bib27","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa011053","article-title":"The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes","volume":"345","author":"de Lemos","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.12.015_bib28","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0735-1097(99)00418-0","article-title":"Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial","volume":"34","author":"Mahaffey","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.12.015_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00063110-200106000-00005","article-title":"Prospective evaluation of adenosine-induced proarrhythmia in the emergency room","volume":"8","author":"Camaiti","year":"2001","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.ahj.2005.12.015_bib30","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0022-2828(95)90073-X","article-title":"Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine","volume":"27","author":"Mullane","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ahj.2005.12.015_bib31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00041552-200309000-00003","article-title":"Adenosine A1 receptor antagonists and the kidney","volume":"12","author":"Modlinger","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ahj.2005.12.015_bib32","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","article-title":"BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy","volume":"105","author":"Gottlieb","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.12.015_bib33","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1001\/archinte.1993.00410230125015","article-title":"Ventricular fibrillation following adenosine administration. A case report","volume":"153","author":"Ben-Sorek","year":"1993","journal-title":"Arch Intern Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870306000147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870306000147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:29:34Z","timestamp":1757568574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870306000147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0002870306000147"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2005.12.015","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post\u2013myocardial infarction patients","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2005.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}